Results 81 to 90 of about 5,992,931 (291)

Feigning Weakness

open access: yesInternational Organization, 2010
AbstractIn typical crisis bargaining models, strong actors must convince the opponent that they are not bluffing and the only way to do so is through costly signaling. However, in a war, strong actors can benefit from tactical surprise when their opponent mistakenly believes that they are weak.
openaire   +5 more sources

Weak function word shift [PDF]

open access: yes, 2004
The fact that object shift only affects weak pronouns in mainland Scandinavian is seen as an instance of a more general observation that can be made in all Germanic languages: weak function words tend to avoid the edges of larger prosodic domains.
Vogel, Ralf
core  

Crucial parameters for precise copy number variation detection in formalin‐fixed paraffin‐embedded solid cancer samples

open access: yesMolecular Oncology, EarlyView.
This study shows that copy number variations (CNVs) can be reliably detected in formalin‐fixed paraffin‐embedded (FFPE) solid cancer samples using ultra‐low‐pass whole‐genome sequencing, provided that key (pre)‐analytical parameters are optimized.
Hanne Goris   +10 more
wiley   +1 more source

Non-invasive imaging through dynamic scattering media via mutual coherence function transmission [PDF]

open access: yesAPL Photonics
Scattering imaging techniques are significant tools in biomedicine and underwater detection. Speckle cross correlation imaging of a moving object makes it possible to reconstruct hidden objects through random media.
Xuan Zhang   +7 more
doaj   +1 more source

Weak measurements are universal

open access: yes, 2005
It is well known that any projective measurement can be decomposed into a sequence of weak measurements, which cause only small changes to the state. Similar constructions for generalized measurements, however, have relied on the use of an ancilla system.
G. Lüders   +6 more
core   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

open access: yesMolecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang   +3 more
wiley   +1 more source

Solid weak BCC-algebras

open access: yes, 2012
We characterize weak BCC-algebras in which the identity $(xy)z=(xz)y$ is satisfied only in the case when elements $x,y$ belong to the same ...
Bunder W. M.   +23 more
core   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

open access: yesMolecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat   +8 more
wiley   +1 more source

(kappa,theta)-weak normality

open access: yes, 2011
We characterize the situation of small cardinality for a product of cardinals divided by an ultrafilter. We develop the notion of weak normality.
Garti, Shimon, Shelah, Saharon
core   +1 more source

Circular RNA expression landscapes in myelodysplastic neoplasms: Associations with mutational signatures and disease progression

open access: yesMolecular Oncology, EarlyView.
In this explorative study, the abundance of circular RNA molecules in bone marrow stem cells was found to be elevated in patients with high‐risk myelodysplastic neoplasms, and to be associated with an increased risk of progression to acute myeloid leukemia.
Eileen Wedge   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy